Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Genky Drug Stores CoTSE:9267 -0.53%79 PEG Ratio is 1.03 as of Jul. 22, 2026, which is at its 10-year median of 1.03. GuruFocus rates TSE:9267 with a GF Score™ of 79/100 and a GF Value™ of 円3,660.97 (Fairly Valued). The stock has 1 warning sign investors should review. Among 225 Healthcare Providers & Services companies, Genky Drug Stores Co ranks better than 64% on this metric.
* The 5-Year EBITDA Growth Rate is the 5-year average EBITDA per share growth rate. While the denominator is a percentage, we use the whole number as opposed to the decimal form for the calculation. For example, 5% would be shown as 5 as opposed to 0.05. If it's smaller than or equal to 0, then the PEG Ratio is not calculated.
The historical rank and industry rank for Genky Drug Stores Co's PEG Ratio or its related term are showing as below:
TSE:9267'
s PEG Ratio Range Over the Past 10 Years
Min: 0.55 Med: 1.03 Max: 6.73
Current: 1.03
During the past 13 years, Genky Drug Stores Co's highest PEG Ratio was 6.73. The lowest was 0.55. And the median was 1.03.
TSE:9267's PEG Ratio is ranked better than 64% of 225
companies
in the Healthcare Providers & Services industry
Industry Median: 1.39
vs TSE:9267: 1.03
Peter Lynch thinks a company with a P/E ratio equal to its growth rate is fairly valued.
Genky Drug Stores Co (TSE:9267) PEG Ratio Explanation
To compare stocks with different growth rates, Peter Lynch invented a ratio called PEG Ratio. PEG Ratio is defined as the P/E ratio divided by the growth ratio. He thinks a company with a P/E ratio equal to its growth rate is fairly valued. Still he said he would rather buy a company growing 20% a year with a P/E of 20, instead of a company growing 10% a year with a P/E of 10.
Genky Drug Stores Co PEG Ratio Related Terms
Genky Drug Stores Co PEG Ratio Historical Data
* Premium members only.
The historical data trend for Genky Drug Stores Co's PEG Ratio can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Genky Drug Stores Co PEG Ratio Competitor Comparison
For the Pharmaceutical Retailers subindustry, Genky Drug Stores Co's PEG Ratio, along with its competitors' market caps and PEG Ratio data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Genky Drug Stores Co PEG Ratio vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, Genky Drug Stores Co's PEG Ratio distribution charts can be found below:
* The bar in red indicates where Genky Drug Stores Co's PEG Ratio falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
* Note: The 5-Year EBITDA Growth Rate is the 5-year average EBITDA per share growth rate. While the denominator is a percentage, we use the whole number as opposed to the decimal form for the calculation. For example, 5% would be shown as 5 as opposed to 0.05. If it's smaller than or equal to 0, then the PEG Ratio is not calculated.
Genky Drug Stores Co (TSE:9267) has a PEG Ratio of 1.03 as of Jul. 22, 2026. Price-earnings to growth ratio is the ratio of price-earnings to a company's earnings growth rate. View historical data on Genky Drug Stores Co and its competitors. This is near median its historical median of 1.03. Over the past decade, Genky Drug Stores Co's PEG Ratio has ranged from 0.55 to 6.73. According to the industry distribution chart, Genky Drug Stores Co ranks #81 out of 225 companies in the Healthcare Providers & Services industry, placing it in the top 36%.
Is Genky Drug Stores Co's PEG Ratio too high?
Genky Drug Stores Co's current PEG Ratio of 1.03 is near median its 10-year median of 1.03. Over the past 10 years, this metric has ranged from a low of 0.55 to a high of 6.73. The Healthcare Providers & Services industry median PEG Ratio is 1.39. Genky Drug Stores Co's value of 1.03 is 25.9% below this industry median. Based on the distribution chart, Genky Drug Stores Co ranks #81 out of 225 companies in the Healthcare Providers & Services industry, which is above the industry midpoint. Overall, Genky Drug Stores Co has a GF Score™ of 79/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Genky Drug Stores Co's PEG Ratio compare to competitors?
According to the Healthcare Providers & Services industry distribution chart, Genky Drug Stores Co ranks #81 out of 225 companies for PEG Ratio. This puts Genky Drug Stores Co in the upper half of its industry. The industry median PEG Ratio is 1.39. Genky Drug Stores Co's value of 1.03 is 25.9% below this benchmark. Historically, Genky Drug Stores Co's own PEG Ratio has ranged from 0.55 to 6.73 over the past decade. While the company's 10-year median is 1.03 vs. the industry median of 1.39, Genky Drug Stores Co has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good PEG Ratio for a Healthcare Providers & Services company?
The median PEG Ratio among Healthcare Providers & Services companies is 1.39, based on 225 companies in the industry. Companies in the top quartile (top 25%) have a PEG Ratio significantly above this median, while those in the bottom quartile fall well below. However, PEG Ratio should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Genky Drug Stores Co's current PEG Ratio of 1.03 is 25.9% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high PEG Ratio mean?
A high PEG Ratio can signal that a stock is expensive relative to its fundamentals. Price-earnings to growth ratio is the ratio of price-earnings to a company's earnings growth rate. View historical data on Genky Drug Stores Co and its competitors. For the Healthcare Providers & Services industry, the median PEG Ratio is 1.39 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Genky Drug Stores Co's current PEG Ratio is 1.03, which is near median its own 10-year median of 1.03. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Genky Drug Stores Co stock overvalued right now?
Based on GuruFocus' analysis, Genky Drug Stores Co (TSE:9267) is currently considered Fairly Valued. The stock's GF Value™ is 円3,660.97, compared to a current price of 円3,750.00 — trading 2.4% above its estimated fair value. The current PEG Ratio is 1.03, which is near median its 10-year median of 1.03 and 25.9% below the Healthcare Providers & Services industry median of 1.39. Genky Drug Stores Co's overall GF Score™ is 79/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is PEG Ratio calculated?
PEG Ratio is calculated from a company's financial statements. For Genky Drug Stores Co (TSE:9267), the current PEG Ratio is 1.03 as of Jul. 22, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Genky Drug Stores Co (TSE:9267) Overvalued in 2026?
Based on GuruFocus' analysis, Genky Drug Stores Co stock appears to be overvalued.
The current stock price of 円3,750.00 is trading 2.4% above its estimated GF Value™ of 円3,660.97.
GuruFocus considers Genky Drug Stores Co to be Fairly Valued.
Key valuation signals for TSE:9267:
PEG Ratio: 1.03 (near median its 10-year median of 1.03)
GF Value™: 円3,660.97 vs. price of 円3,750.00 (2.4% above fair value)
Industry Position: 25.9% below the Healthcare Providers & Services median (#81 of 225)
No single metric tells the full story. See the TSE:9267 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
TSE:9267 has been successfully added to your 
